Search…

Tianxing Medical (01609.HK) spent approximately HK$430,100 to repurchase 8,000 shares on October 27.

27/10/2026

Zhitong Finance APP News, TIANXING MEDICAL (01609.HK) announced that on October 27, 2026, the company spent approximately HK$430,100 to repurchase 8,000 shares at a repurchase price of HK$52.95 to HK$55.8 per share.

Latest

1 m ago

CSPC Pharmaceutical Group (01093.HK): The Phase I/II clinical study results of SYS6043 (B7-H3 ADC) for the treatment of advanced breast cancer were presented as a rapid oral presentation at the 2026 ESMO Congress.

1 m ago

Jinyuan Co., Ltd. (000546.SZ) released its performance for the first three quarters, with a net loss attributable to shareholders of RMB 225 million.

5 m ago

Zhejiang University Insigma (600797.SH) released its first three quarters performance, with a net loss attributable to shareholders of RMB 59.39 million.

5 m ago

Norwegian Cruise Line and Carnival Cruise Line shares erase losses, turn positive in premarket.

5 m ago

CSPC Pharmaceutical Group (01093.HK): Results from the Phase I/II Clinical Study of the Anti-PD-1/IL-15 Bifunctional Fusion Protein SYS6090 (JMT108) as Monotherapy for Advanced Solid Tumors Presented as a Rapid Oral Presentation at the 2026 ESMO Congress

+852 - 60190728

Customer Support

Commercial Services